High self-rated brain problems often mean real issues in MS

High self-rated brain problems often mean real issues in MS
Credibility
Interest
Key Takeaway

When people with MS report many cognitive problems on a questionnaire, it often signals real thinking difficulties, but small worries may not.

What They Found

Researchers looked at 933 people with MS who completed both a short self-report questionnaire about thinking problems (PDQ) and formal thinking tests (MACFIMS).They found that almost half (about 47%) of participants had measurable thinking problems on the tests, which is a lot higher than in the general population.People who scored 50 or higher on the PDQ — meaning they reported many cognitive concerns — were nearly twice as likely to have measurable thinking problems on the formal tests.For people who scored below 50 on the PDQ, reporting fewer concerns did not relate to having problems on the tests — so small or occasional worries weren’t a good sign of real impairment.This shows the relationship is not straight-line: only after a certain point (PDQ ≥ 50) do self-reports match up with tested thinking problems.

Who Should Care and Why

People with MS should care because if you often notice memory slips, trouble concentrating, or slowed thinking and score high on a PDQ-like survey, it may be a sign to ask for formal testing or support.Caregivers can use this as a simple rule: many repeated concerns deserve attention, while a few occasional lapses may not mean a serious problem — similar to how one missed appointment is different from missing many.Health providers can use a high PDQ score as a useful red flag to recommend further cognitive testing, therapy, or daily-life supports like reminders and planning tools.This finding can change daily routines: for example, someone with many self-reported problems might benefit from writing things down, using phone reminders, or simplifying tasks to reduce errors.People with anxiety or depression should note that these feelings were considered in the study, so a high PDQ score still mattered even when mood was accounted for — but mood can also affect how people notice cognitive problems.

Important Considerations

This study was done at one clinic and mainly included middle-aged adults, so results might not be exactly the same for children, very old adults, or people in different places.The PDQ is a self-report tool — what people notice can be influenced by mood, stress, or personality — so the questionnaire isn’t perfect by itself for diagnosing problems.While a PDQ score of 50 or more was linked to test-based impairment, scores below 50 don’t rule out problems; if you’re worried, discuss testing with your care team.

AI-generated summary — for informational purposes only, not medical advice

Article Topics:
CognitionMultiple sclerosisNeuropsychologySubjective cognitive concerns

You May Also Like

Gut Bacteria and MS: What You Need to Know
Gut Bacteria and MS: What You Need to Know

12/31/2026

Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li

Read More
CD29: A Blood Clue to MS B Cells and Treatment Response
CD29: A Blood Clue to MS B Cells and Treatment Response

5/1/2026

Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in

Read More
What MS Patients Should Know About PML and Recovery
What MS Patients Should Know About PML and Recovery

5/1/2026

Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes

Read More
Fewer Hospital Cases of Certain Brain Autoimmunity During COVID
Fewer Hospital Cases of Certain Brain Autoimmunity During COVID

5/1/2026

Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b

Read More
A key immune switch behind MS-type inflammation
A key immune switch behind MS-type inflammation

4/6/2026

Study finds NIK in myeloid cells boosts IL-23 and activates disease-driving T cells—pointing to a po

Read More
How a Common Virus May Trigger MS Attacks
How a Common Virus May Trigger MS Attacks

3/17/2026

Study links Epstein-Barr virus protein to immune attacks on brain proteins in MS, explaining a possi

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.